Clinical Research Directory
Browse clinical research sites, groups, and studies.
Obstructive Sleep Apnea Treatment in Serious Mental Illness
Sponsor: University of California, San Diego
Summary
Serious mental illnesses (SMI) like schizophrenia and bipolar disorder are two of the most disabling and costly chronic illnesses worldwide. A high proportion of adults with schizophrenia and bipolar disorder have sleep disorders, like obstructive sleep apnea (OSA), but tend to be underdiagnosed and undertreated compared to the general population. This study aims to examine feasibility, acceptance, and impact of OSA treatment and how it affects cognitive function in people with SMI.
Official title: Obstructive Sleep Apnea Treatment in People Aging With Serious Mental Illness
Key Details
Gender
All
Age Range
40 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
300
Start Date
2025-01-01
Completion Date
2026-11
Last Updated
2024-07-10
Healthy Volunteers
Yes
Interventions
Automatic Positive Airway Pressure (APAP)
If eligible, participants will be given a clinical Automatic Positive Airway Pressure (APAP) device for up to 3 months, while they are waiting for their clinical evaluation from a sleep physician. The APAP device will we will be using is the ResMed Airsense 11 Autoset. APAP is a smart positive airway pressure (PAP) device, where the pressure changes as needed to provide optimal pressure to splint the upper airway. Dr. Lee and Dr. Schmickl will oversee management of the device. During the first month of APAP use, individuals will participate in weekly phone calls or in-person visits to ensure optimal adherence and troubleshoot any issues (improper mask fitting, discomfort, etc) that may arise.
Locations (1)
UCSD
La Jolla, California, United States